A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal (Agalsidase Alfa) Enzyme Replacement Therapy in Canadian Patients With Fabry Disease
Clinical trial NCT01298141 · COMPLETED
Trial details
- NCT number
- NCT01298141
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-10
- Primary completion
- 2017-09-25
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.